Kadimastem Awarded Patent in Japan for AstroRx速 For ALS and Drug Screening
yahoo.com
news
2022-05-30 13:10:18

DGAP-News: Kadimastem

Kadimastem Awarded Patent in Japan for AstroRx速 For ALS and Drug Screening



The issuer is solely responsible for the content of this announcement.

Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company developing a treatment for ALS, exploring one for multiple sclerosis and developing a potential cure for diabetes, has received a patent from the Japan Patent Office for AstroRx速 for the treatment of ALS and drug screening. The patent also protects AstroRx速 for the treatment of multiple sclerosis.
